22 Jul, 2021 By Humatica
Humatica’s new whitepaper on Buy & Build. Download now
Humatica’s new whitepaper on Buy & Build. Download now
Humatica’s new whitepaper on Buy & Build. Download now
Latest news on Humatica, our people, projects and events. For further updates, please view our LinkedIn page.
View Insights
22 Jul, 2021 By Humatica
What is your position and what do you do on a day-to-day basis? I am a consultant at Humatica. There is no such thing as…
Read more
Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, has advised Baird Capital’s private equity team on its investment in Azzur Group. Azzur is a provider of professional…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Freshstream on its investment in a group containing the UK’s leading security technologists, including SmartWater® and Perimeter…
Read more
Despite the pandemic, Humatica had a record 2020. We completed 31 international projects, 23 of which were delivered remotely. We worked closely with our loyal…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Intermediate Capital Group (ICG) on its investment in Lucid Group. Founded in 2007, Lucid Group is a…
Read more
Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to have supported HVD Partners and the Solifos AG management with the…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has appointed Enno Krey as the firm’s Digital Products Lead based in London. This…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, is proud to announce four promotions in its London office. Abhash Bhattacharya (Dutch/Indian), who…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, is proud to announce its cooperation with DotProjects to offer Humatica’s services and local…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Baird Capital on its acquisition of a majority interest in eCube Solutions Limited, a leading aircraft disassembly…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, is proud to announce its cooperation with Icknield Ltd., a leading UK restructuring and…
Read more
Humatica, the leading private equity specialist advisor for portfolio organisational effectiveness, is proud to announce five promotions in its London and Zurich offices. Valentina Pozzobon…
Read more
Humatica, the leading specialist private equity advisor focused on organisational effectiveness, has appointed Jaroslav Filak as a Consultant in its Zurich office. Jaroslav will support…
Read more
Congratulations to the Humatica team for another record year of growth. We have had the privilege of serving some of the most demanding private equity sponsors…
Read more
Humatica is proud to be sponsoring the PEI Operating Partners Forum Europe 2020 in London on 5-6 October. The event will be held at the…
Read more
Humatica is proud to have become a member of the British Private Equity & Venture Capital Association (BVCA). The BVCA is the industry body for…
Read more
Humatica is proud to be sponsoring Real Deals Value Creation Conference 2020 in Munich on 24 September. The event will be held at the Courtyard…
Read more
PRESS RELEASE Zurich, 29th August 2019 Andreas Knobloch strengthens Humatica team in Germany Humatica AG has appointed Andreas Knobloch as a senior member…
Read more
Humatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the…
Read more
Congratulations to the Humatica team for completing their 260th project to improve organisational performance and value – providing specialized services for private equity backed companies,…
Read more
Humatica Ltd. has moved to new premises in the heart of Mayfair, located on the corner of Hanover Square and Harewood Place. The new office…
Read more
Humatica Ltd. was retained to advise the Riverside Company on its significant investment in E&A Scheer (Scheer), the largest global blender and vendor of premium…
Read more
Humatica AG was retained to advise Summa Equity on its majority investment in Infobric AB (“Infobric”), a provider of software and hardware for attendance systems,…
Read more
Humatica Managing Partner Patrick Mina has been interviewed for the October issue of Finance Monthly. Read full article
Read more
Humatica AG was retained to advise Summa Equity on its majority investment in Lakers Holding AB (“Lakers”), a Nordic group operating within the water, wastewater,…
Read more
Humatica has supported Solifos AG’s management and HVD Partners with the carve out and rapid turn-around of the former Brugg Cables company active in fiber…
Read more
A letter from the founder This month marks our 15th year serving private equity investors and portfolio company management teams. In an otherwise turbulent business environment…
Read more
Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm…
Read more
Humatica Ltd. was retained to advise Baird Capital on its acquisition of a majority interest in Collingwood Lighting, a leading designer and supplier of residential,…
Read more
Humatica Ltd. was retained to advise the Riverside Company on its investment in Swiss manufacturer TECSEDO RE through Panels S.A., a portfolio holding of The…
Read more
Please click on the link to view full Press Release Humatica supports Partners Group and Capvis
Read more
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products…
Read more
Humatica´s next Organisational Excellence breakfast seminar will take place at The Ritz Hotel, London, on 27th September. A lively discussion on “Identifying organisational bottlenecks post-signing…
Read more
More funds are appointing specialised Operating Partners to help align portfolio company organisations for value growth. However, the emerging role is not yet well defined…
Read more
Increased competitiveness and technology are driving “always-on” availability of deal makers. However, is this a good thing? Humatica was recently quoted on the topic in…
Read more
Humatica Ltd. was retained to advise Baird Capital, on its recent investment in Prescient Healthcare Group. Please click on the link below to view the…
Read more
Managing Secondaries – The good, the bad and the ugly Secondaries are more commonplace. However, a change of ownership from one PE house to the…
Read more
Over 50% of buy-out CEOs don’t get to see an investment all the way through. And, in private equity, the trend to replace senior executives…
Read more
In the latest RealDeals Guest Comment article, Andros Payne, discusses learning the secret of how successful operating partners drive change without formal authority… Read full…
Read more
Operating Partners have the most difficult job in Private Equity. They should facilitate transformational change post-deal, but without formal authority. Our experience shows that those…
Read more
A lack of economic growth despite record low interest rates, rising populist discontent and mounting unfunded pension liabilities in the developed economies: they have the same…
Read more
With record private equity assets under management and US$1.3 trillion of dry powder, insiders are nervous. How will this money be deployed and generate a…
Read more
Humatica has been an advocate for a more assertive PE investment approach focusing on leadership and organisational performance since 2003. In this month’s InFocus HR guru Dr.…
Read more
Women are running four of the world’s top democracies and with Hillary Clinton, may soon be running the fifth. Times have changed indeed. The ideals…
Read more
Standards and compliance requirements are increasing everywhere. However, the essential leadership processes for making and implementing decisions to grow value are often left to each…
Read more
Most people avoid conflict. It’s anti-social. However, sometimes this gets in the way of making good business decisions. This month’s InFocus features a recent interview with Ray Dalio,…
Read more
“A well executed reorganisation can be one of the most liberating events in a company’s history, releasing power and talent”. In the latest edition of…
Read more
It’s a natural response to a faster competitive environment – company’s are reorganising more frequently than ever. However, anticipated benefits often don’t materialise. Instead, structural changes…
Read more
97% of private equity investors confirm that personnel issues are a key reason for not achieving targeted IRR. Clearly, sponsors need more transparency in this…
Read more
Deal markets are competitive. It’s more difficult to get quality information on targets – especially on critical soft-factors like leadership and the organisation. This month’s InFocus features a…
Read more
“Specialisation runs out of steam when you can’t connect the dots on patterns of risk or opportunity, which is really what private equity is all about,” Read…
Read more
Humatica is proud to announce that it will be sponsoring the Private Equity International Operating Partners Forum Europe 2016. The event will be held at…
Read more
Patrick Mina has joined Humatica as its new Managing Partner UK. Patrick is responsible for managing Humatica’s operations in the UK and is active on…
Read more
Private equity has grown in scale and maturity, with multi-billion funds having hundreds of employees and offering diverse financial services. In an era of diminishing…
Read more
Hiring the right people is frustratingly difficult. The number of dimensions on which there needs to be a fit are large. Some can be tested…
Read more
Hiring the right people is frustratingly difficult. The number of dimensions on which there needs to be a fit are large. Some can be tested…
Read more
A recent article on growthbusiness.co.uk discusses the results from Humatica’s new study “The Third Wave: Organisational due diligence – Riding the next wave of value…
Read more
New Humatica Research Too many funds. Too much liquidity. Too high deal prices. Fund managers are asking themselves what’s next after Operational Excellence? How will…
Read more
In the October issue of Acquisition International Humatica consultant Valentina Pozzobon discusses how organisational due diligence can be incorporated successfully into business deals. “Considering merger…
Read more
Despite huge efforts to improve operational processes over the past 20 years, critically important management processes are left up to the discretion of each manager…
Read more
In an article published in last week’s issue of RealDeals Humatica’s Andros Payne explores what the Volkswagen value collapse says about knowledge worker behaviour, productivity…
Read more
“GPs know that it is important to bring operational capabilities to their deals if they want to make stellar returns. But in overlooking the importance of soft factors they are missing out…
Read more
Volksvagen | VW Now, with the benefit of hindsight, it is a stupid surprise. How is it that a group of employees at VW could…
Read more
The transition into a new executive role in private equity is tough. The performance demands and rigour of private equity’s active governance model can be…
Read more
Humatica is one of the proud sponsors of RealDeals’ European Mid-Market conference at the Renaissance Amsterdam Hotel on the 23rd of October 2015. Join us…
Read more
It is notoriously difficult for new buy-out CEOs to make the jump to private equity. The skills and competencies required to fulfil rigorous performance requirements are…
Read more
In the industry report “The Private Equity Job Market Is Hot In 2015” Valerie Thompson investigates how big the current war for talent in Private…
Read more
Operational processes have been re-engineered to perfection over the past 20 years. However, management decision-making processes that sit above them, are still left up to individual…
Read more
About the Interviewee NORMAN WALKER is an advisor to TPG Capital for portfolio company organisational and leadership issues. He leads his own firm Ardfern AG,…
Read more
Dr. Ulrich Bergmoser, Partner at Humatica, presented at the “European Restructuring Day” to more than 200 refinancing and restructuring experts, corporate executives, top management representatives…
Read more
Private equity’s governance structure places unique and high demands on senior executives. They are at the fulcrum of the capitalist system, balancing the requirements of…
Read more
Dr. Ulrich Bergmoser has joined Humatica in the capacity of Managing Partner DACH. He is based in London and has more than 20 years of…
Read more
The latest issue of RealDeals magazine features an article on how a mid-market buy-out increased enterprise value 3x by shifting culture over the course of…
Read more
All the easy levers have been pulled – purchasing cost reduction, a new strategy – so what’s next? Private equity sponsors are increasingly looking at…
Read more
What are the real reasons for roughly half of all mergers failing to generate their cost of capital? In the latest edition of Acquisition International…
Read more
Getting the culture right is critical for merger success. The greatest risk for failure is culture clash, a breakdown of trust, and the resulting stagnation. Merging…
Read more
Humatica is one of the proud sponsors of Unquote’s Nordic Private Equity Forum at the beautiful Grand Hotel, Stockholm, on the 5th of May. The…
Read more
Private equity leaders are faced with a massive challenge – how to grow revenues and value in slow-growth markets. Shifting white-collar productivity and improving behaviour…
Read more
The survival rate of private equity portfolio company CEOs is shockingly low. And the cost of changing the CEO in terms of lost time, effort and…
Read more
In the latest edition of Real Deals magazine Humatica’s Andros Payne contributes with his views on why the half-life of private equity-backed chief executives is…
Read more
We are honoured to announce that Humatica has been shortlisted for the prestigious Private Equity Awards 2015. As a result of our extensive work with…
Read more
Norman Walker, Humatica’s new Advisory Board member, is an advisor to TPG Capital for portfolio company organisational and leadership issues. He also leads his own…
Read more
Individual performance feedback is one of the toughest management processes to get right because it runs against the basic human nature of social interaction in…
Read more
Humatica’s CEO, Andros Payne, contributes his thoughts to the latest Merrill DataSite white paper on value creation across the private equity life cycle. Read the report…
Read more
Recent issue of PEI Operational Excellence: Keynote Interview with Erik Osmundsen, CEO of Altor’s portfolio company NorskGjenvinning and Andros Payne, Humatica The success of Altor’s…
Read more
Humatica has strengthened its team with the addition of Reine Wasner. Reine brings deep consulting and line management experience. He was previously the head of…
Read more
Over 300 UK private equity investors and experts convened at the prestigious Landmark Hotel in central London. They discussed a range of topics fundamental to the…
Read more
Humatica has completed 2013 with another year of profitable growth. Although the firm does not publish financial figures, Andros Payne commented, “We have had an…
Read more
In today’s fast–moving markets, value creation comes from an organisation’s ability to collectively anticipate change, says Andros Payne, CEO of Humatica. More than a century…
Read more
Private Equity International has chosen Humatica as a selected sponsor of its flagship European event for private equity operating partners. With over 100 attendees for…
Read more
Humatica celebrated 10 years of profitable growth with a gathering of past clients, friends and partners in a private dinner at Zurich’s exclusive Hotel Widder.…
Read more
Andy Cook has joined Humatica in the UK to strengthen the senior team and drive further expansion of work in the United Kingdom. Andy joins…
Read more
Humatica hosted a private dinner with leading investors on the topic of “Getting the organisation right”. Participants from leading funds, including Advent International, 3i, Elysian,…
Read more
Receive our news and valuable perspectives on organizational effectiveness each month.